Alphamab Oncology
HKEX:9966

Watchlist Manager
Alphamab Oncology Logo
Alphamab Oncology
HKEX:9966
Watchlist
Price: 10.67 HKD 4.3% Market Closed
Market Cap: 10.4B HKD

Intrinsic Value

The intrinsic value of one Alphamab Oncology stock under the Base Case scenario is hidden HKD. Compared to the current market price of 10.67 HKD, Alphamab Oncology is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Alphamab Oncology Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Alphamab Oncology

Intrinsic Value History
Dive into the past to invest in the future

Alphamab Oncology looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Alphamab Oncology usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Alphamab Oncology?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Alphamab Oncology valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Alphamab Oncology.

Explain Valuation
Compare Alphamab Oncology to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Alphamab Oncology?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alphamab Oncology

Current Assets 1.8B
Cash & Short-Term Investments 1.6B
Receivables 108.3m
Other Current Assets 82.1m
Non-Current Assets 523.8m
PP&E 522.4m
Other Non-Current Assets 1.4m
Current Liabilities 368.7m
Accounts Payable 53.3m
Accrued Liabilities 118m
Other Current Liabilities 197.5m
Non-Current Liabilities 135.2m
Long-Term Debt 114.1m
Other Non-Current Liabilities 21.2m
Efficiency

Free Cash Flow Analysis
Alphamab Oncology

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Alphamab Oncology

Revenue
786m CNY
Cost of Revenue
-60.8m CNY
Gross Profit
725.2m CNY
Operating Expenses
-527.3m CNY
Operating Income
197.9m CNY
Other Expenses
34.9m CNY
Net Income
232.8m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Alphamab Oncology's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional ROIC
Exceptional Gross Margin
ROE is Increasing
hidden
Profitability
Score

Alphamab Oncology's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Alphamab Oncology's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Alphamab Oncology's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Alphamab Oncology

Wall Street analysts forecast Alphamab Oncology stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Alphamab Oncology is 7.14 HKD with a low forecast of 7.07 HKD and a high forecast of 7.35 HKD.

Lowest
Price Target
7.07 HKD
34% Downside
Average
Price Target
7.14 HKD
33% Downside
Highest
Price Target
7.35 HKD
31% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

Alphamab Oncology
does not pay dividends
Shareholder Yield

Current shareholder yield for Alphamab Oncology is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Alphamab Oncology stock?

The intrinsic value of one Alphamab Oncology stock under the Base Case scenario is hidden HKD.

Is Alphamab Oncology stock undervalued or overvalued?

Compared to the current market price of 10.67 HKD, Alphamab Oncology is hidden .

Back to Top